Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population

被引:40
作者
Mühlberg, T
Herrmann, K
Joba, W
Kirchberger, M
Heberling, HJ
Heufelder, AE
机构
[1] Univ Marburg, Zentrum Innere Med, Div Endocrinol & Metab, Dept Internal Med, D-35033 Marburg, Germany
[2] Stadt Klinikum Leipzig W, D-04177 Leipzig, Germany
关键词
D O I
10.1210/jc.85.8.2640
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Constitutively activating mutations of the human TSH receptor (hTSHR) gene have been implicated as a major cause of hyperfunctioning nonautoimmune thyroid disease. However, significant geographic differences in the prevalence of these mutations have been observed. Recently, a high frequency of a germline polymorphism at codon 727 of the cytoplasmic tail of the hTSHR has been demonstrated in patients with toxic multinodular goiter. In the present study we assessed whether the codon 727 polymorphism is associated with hyperfunctioning thyroid adenomas. PCR followed by restriction enzyme digestion were used to genotype a total of 128 European Caucasian patients with toxic nonautoimmune thyroid disease (83 with toxic adenoma, 31 with toxic multinodular goiter, and 14 with disseminated autonomy) and to compare their codon 727 polymorphism frequencies with those of 99 healthy controls and 108 patients with Graves' disease. All individuals were drawn from an identical ethnic background. Sequencing of PCR products was used to confirm the mutation analysis. We found no significant differences in codon 727 polymorphism frequencies between patients with autonomously functioning thyroid disorders (13.3%) and the healthy control group (16.2%; P = 0.57). Moreover, the subtypes of toxic nonautoimmune thyroid disease (toxic adenoma, 13.2%; multinodular goiter, 9.6%; disseminated autonomy, 21.4%) were not related to significant differences in codon 727 polymorphism frequencies compared with the healthy control group (P = 0.67, P = 0.40, and P = 0.70, respectively). Additionally, there were no significant differences between patients with Graves' disease (21.3%) and healthy controls (P = 0.38). In conclusion, our data do not support an association between the codon 727 polymorphism of the hTSHR and toxic thyroid adenomas or toxic multinodular goiter in our study population. Thus, the codon 727 polymorphism of the hTSHR does not appear to be involved in the evolution of autoimmune or nonautoimmune hyperthyroidism in the European Caucasian population.
引用
收藏
页码:2640 / 2643
页数:4
相关论文
共 20 条
[1]   Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features [J].
Arturi, F ;
Capula, C ;
Chiefari, E ;
Filetti, S ;
Russo, D .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (03) :234-236
[2]   Constitutive activation of the G(s)alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas [J].
Derwahl, M ;
Hamacher, C ;
Russo, D ;
Broecker, M ;
Manole, D ;
Schatz, H ;
Kopp, P ;
Filetti, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1898-1904
[3]   Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene [J].
Duprez, L ;
Hermans, J ;
VanSande, J ;
Dumont, JE ;
Vassart, G ;
Parma, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :306-308
[4]   Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain [J].
Duprez, L ;
Parma, J ;
Costagliola, S ;
Hermans, J ;
VanSande, J ;
Dumont, JE ;
Vassart, G .
FEBS LETTERS, 1997, 409 (03) :469-474
[5]   Somatic mutations in the thyrotropin receptor gene and not in the G(s)alpha protein gene in 31 toxic thyroid nodules [J].
Fuhrer, D ;
Holzapfel, HP ;
Wonerow, P ;
Scherbaum, WA ;
Paschke, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3885-3891
[6]   Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter [J].
Gabriel, EM ;
Bergert, ER ;
Grant, CS ;
van Heerden, JA ;
Thompson, GB ;
Morris, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) :3328-3335
[7]   Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters [J].
Holzapfel, HP ;
Führer, D ;
Wonerow, P ;
Weinland, G ;
Scherbaum, WA ;
Paschke, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4229-4233
[8]   THYROID EXPRESSION OF AN A2 ADENOSINE RECEPTOR TRANSGENE INDUCES THYROID HYPERPLASIA AND HYPERTHYROIDISM [J].
LEDENT, C ;
DUMONT, JE ;
VASSART, G ;
PARMENTIER, M .
EMBO JOURNAL, 1992, 11 (02) :537-542
[9]  
MUCA C, 1994, ONCOGENE, V9, P3647
[10]   Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of Gαs [J].
Murakami, M ;
Kamiya, Y ;
Yanagita, Y ;
Koitabashi, H ;
Nagamachi, Y ;
Hosoi, Y ;
Ogiwara, T ;
Mizuma, H ;
Iriuchijima, T ;
Mori, M .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 138 (1-2) :137-142